Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

NCT00263159 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 221

Last updated 2007-12-28

No results posted yet for this study

Summary

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Conditions

Interventions

PROCEDURE

Pharmaceutical care for asthma patients

Sponsors & Collaborators

  • University Ghent

    lead OTHER

Principal Investigators

  • Guy Brusselle, MD, PhD · University Hospital, Ghent

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Completion
2006-10-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00263159 on ClinicalTrials.gov